CA3207723A1 - Methods for predicting risk of interstitial pneumonia - Google Patents
Methods for predicting risk of interstitial pneumoniaInfo
- Publication number
- CA3207723A1 CA3207723A1 CA3207723A CA3207723A CA3207723A1 CA 3207723 A1 CA3207723 A1 CA 3207723A1 CA 3207723 A CA3207723 A CA 3207723A CA 3207723 A CA3207723 A CA 3207723A CA 3207723 A1 CA3207723 A1 CA 3207723A1
- Authority
- CA
- Canada
- Prior art keywords
- marker
- gene
- interstitial lung
- subject
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361764986P | 2013-02-14 | 2013-02-14 | |
| US61/764,986 | 2013-02-14 | ||
| CA2900073A CA2900073C (en) | 2013-02-14 | 2014-02-14 | Methods for predicting risk of interstitial pneumonia |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2900073A Division CA2900073C (en) | 2013-02-14 | 2014-02-14 | Methods for predicting risk of interstitial pneumonia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3207723A1 true CA3207723A1 (en) | 2014-08-21 |
Family
ID=51354692
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3207723A Pending CA3207723A1 (en) | 2013-02-14 | 2014-02-14 | Methods for predicting risk of interstitial pneumonia |
| CA2900073A Active CA2900073C (en) | 2013-02-14 | 2014-02-14 | Methods for predicting risk of interstitial pneumonia |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2900073A Active CA2900073C (en) | 2013-02-14 | 2014-02-14 | Methods for predicting risk of interstitial pneumonia |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10752952B2 (enExample) |
| EP (3) | EP2956555A4 (enExample) |
| JP (1) | JP6530717B2 (enExample) |
| KR (5) | KR102398430B1 (enExample) |
| CN (1) | CN105143467B (enExample) |
| CA (2) | CA3207723A1 (enExample) |
| HK (1) | HK1219115A1 (enExample) |
| MX (2) | MX375503B (enExample) |
| RU (1) | RU2670148C2 (enExample) |
| WO (1) | WO2014127290A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102398430B1 (ko) | 2013-02-14 | 2022-05-13 | 더 리전츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코퍼레이트 | 간질 폐렴의 위험을 예측하는 방법 |
| WO2015198144A2 (en) | 2014-06-27 | 2015-12-30 | Techflux, Ltd. | Method and device for transmitting data unit |
| WO2017066712A2 (en) | 2015-10-16 | 2017-04-20 | The Children's Medical Center Corporation | Modulators of telomere disease |
| WO2017066796A2 (en) * | 2015-10-16 | 2017-04-20 | The Children's Medical Center Corporation | Modulators of telomere disease |
| WO2017121769A1 (en) * | 2016-01-12 | 2017-07-20 | bioMérieux | In vitro method for predicting a risk of developing pneumonia in a subject |
| US20200171024A1 (en) | 2017-06-26 | 2020-06-04 | The Regents Of The University Of Colorado, A Body Corporate | Biomarkers for the diagnosis and treatment of fibrotic lung disease |
| EP3652749A4 (en) * | 2017-07-14 | 2021-03-24 | The Regents of The University of California | NEW PROCESSES FOR PREDICTING THE RISK OF GRAFT REJECTION |
| CN107677835B (zh) * | 2017-09-26 | 2019-08-09 | 上海市肺科医院 | 一种ae-ipf的蛋白标记物及其应用 |
| CN112118781A (zh) * | 2018-03-12 | 2020-12-22 | 加利福尼亚大学董事会 | 通过t细胞受体亚基库多样性的分析评估移植排斥状态 |
| CA3101527A1 (en) * | 2018-06-06 | 2019-12-12 | Lexent Bio, Inc. | Methods for fingerprinting of biological samples |
| CN108660206B (zh) * | 2018-08-14 | 2022-11-22 | 天佳吉瑞基因科技有限公司 | 预测或辅助预测肺部辐射后患放射性肺炎风险的遗传生物标记物及其应用 |
| CN110184355A (zh) * | 2019-06-06 | 2019-08-30 | 四川大学华西第二医院 | 一种与宫颈鳞癌发生发展相关的生物标志物及其应用 |
| JP7300642B2 (ja) * | 2019-06-14 | 2023-06-30 | 国立大学法人浜松医科大学 | 特発性肺線維症の予後予測方法 |
| RU2720713C9 (ru) * | 2020-03-27 | 2020-05-18 | Евгений Олегович Рубальский | Набор синтетических олигонуклеотидов для выявления рнк коронавируса |
| RU2732608C1 (ru) * | 2020-04-09 | 2020-09-21 | Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации | Набор реагентов для выявления РНК вируса SARS-CoV-2, возбудителя нового коронавирусного заболевания COVID-2019, методом обратной транскрипции-полимеразной цепной реакции в реальном времени |
| RU2727054C1 (ru) * | 2020-04-24 | 2020-07-17 | Сергей Феликсович Дрозд | Способ выявления кДНК коронавируса SARS-CoV-2 с помощью синтетических олигонуклеотидных праймеров в полимеразной цепной реакции |
| JP7570088B2 (ja) * | 2020-06-18 | 2024-10-21 | 国立研究開発法人産業技術総合研究所 | 情報処理システム、情報処理方法、同定方法及びプログラム |
| DE102020005556B4 (de) | 2020-09-02 | 2023-07-06 | Gesellschaft für Individualisierte Medizin mbH | Verfahren zur Prognose der Schwere des Verlaufs einer COVID-19-Erkrankung |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US6825047B1 (en) | 1996-04-03 | 2004-11-30 | Applera Corporation | Device and method for multiple analyte detection |
| US7235406B1 (en) | 1996-04-03 | 2007-06-26 | Applera Corporation | Nucleic acid analysis device |
| US6272939B1 (en) | 1999-10-15 | 2001-08-14 | Applera Corporation | System and method for filling a substrate with a liquid sample |
| US20020197646A1 (en) * | 2001-02-14 | 2002-12-26 | Nogee Lawrence M. | Single nucleotide polymorphisms associated with interstitial lung disease |
| US6514750B2 (en) | 2001-07-03 | 2003-02-04 | Pe Corporation (Ny) | PCR sample handling device |
| DK2529033T3 (en) * | 2010-01-26 | 2017-08-07 | Nat Jewish Health | PROCEDURES FOR PREVENTING THE RISK OF, DIAGNOSTICATION AND PROJECTING OF LUNG DISEASES |
| US20120034214A1 (en) * | 2010-07-22 | 2012-02-09 | Isis Innovation Limited | Methods and kits for determining the prognosis of pulmonary sarcoidosis |
| KR102398430B1 (ko) | 2013-02-14 | 2022-05-13 | 더 리전츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코퍼레이트 | 간질 폐렴의 위험을 예측하는 방법 |
-
2014
- 2014-02-14 KR KR1020217015148A patent/KR102398430B1/ko active Active
- 2014-02-14 CA CA3207723A patent/CA3207723A1/en active Pending
- 2014-02-14 KR KR1020227015561A patent/KR102544414B1/ko active Active
- 2014-02-14 KR KR1020237019718A patent/KR102719212B1/ko active Active
- 2014-02-14 CN CN201480018768.XA patent/CN105143467B/zh active Active
- 2014-02-14 EP EP14751579.5A patent/EP2956555A4/en not_active Withdrawn
- 2014-02-14 EP EP17169995.2A patent/EP3252169B1/en active Active
- 2014-02-14 RU RU2015138992A patent/RU2670148C2/ru active
- 2014-02-14 MX MX2015010406A patent/MX375503B/es active IP Right Grant
- 2014-02-14 KR KR1020247034107A patent/KR102768285B1/ko active Active
- 2014-02-14 EP EP22159018.5A patent/EP4039821A3/en active Pending
- 2014-02-14 HK HK16107058.6A patent/HK1219115A1/zh unknown
- 2014-02-14 WO PCT/US2014/016601 patent/WO2014127290A2/en not_active Ceased
- 2014-02-14 KR KR1020157024820A patent/KR102264761B1/ko active Active
- 2014-02-14 JP JP2015558170A patent/JP6530717B2/ja active Active
- 2014-02-14 CA CA2900073A patent/CA2900073C/en active Active
-
2015
- 2015-07-30 US US14/813,559 patent/US10752952B2/en active Active
- 2015-08-12 MX MX2020010147A patent/MX2020010147A/es unknown
-
2020
- 2020-07-14 US US16/928,436 patent/US11976328B2/en active Active
-
2024
- 2024-04-10 US US18/631,414 patent/US20240271215A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11976328B2 (en) | Methods for predicting risk of interstitial pneumonia | |
| CN101679971A (zh) | 青光眼恶化风险的判定方法 | |
| US20070092892A1 (en) | Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states | |
| AU2016293381A1 (en) | Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor | |
| WO2014020048A1 (en) | Hyal2 methylation and expression as a cancer marker | |
| US20130096178A1 (en) | Genetic markers for paget's disease | |
| HK40078332A (en) | Methods for predicting risk of interstitial pneumonia | |
| HK1248769B (en) | Methods for predicting risk of interstitial pneumonia | |
| US20110177963A1 (en) | Variation in the CHI3L1 Gene Influences Serum YKL-40 Levels, Asthma Risk and Lung Function | |
| BR122023008110B1 (pt) | Método in vitro e/ou ex vivo para determinar se um sujeito humano apresenta ou está em risco de desenvolver doença pulmonar intersticial | |
| BR112015019502B1 (pt) | Método in vitro e/ou ex vivo para determinar se um sujeito humano apresenta ou está em risco de desenvolver doença pulmonar intersticial | |
| BR122023008116B1 (pt) | Método in vitro e/ou ex vivo para avaliar a eficácia do tratamento contra a doença pulmonar intersticial em um sujeito humano | |
| KR20180125911A (ko) | 차세대서열분석 스크리닝을 통해 발굴한 단일염기다형성에 의한 염증성 장질환의 예측 또는 진단에 관한 정보 제공 방법 | |
| KR20250118434A (ko) | 알츠하이머병 발병 위험도 예측을 위한 레이 복잡도 지연 회상 점수 저하와 관련이 있는 단일염기다형성 마커 및 이의 용도 | |
| WO2025006972A1 (en) | Methods, compositions, and systems to detect head and neck cancer in saliva samples | |
| KR20180125778A (ko) | 차세대서열분석 스크리닝을 통해 발굴한 단일염기다형성에 의한 염증성 장질환의 예측 또는 진단에 관한 정보 제공 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230727 |
|
| EEER | Examination request |
Effective date: 20230727 |
|
| EEER | Examination request |
Effective date: 20230727 |
|
| EEER | Examination request |
Effective date: 20230727 |
|
| EEER | Examination request |
Effective date: 20230727 |